<DOC>
	<DOCNO>NCT01790087</DOCNO>
	<brief_summary>This study design compliance ICH-E14 guideline ( 2005 ) evaluate effect ANX-188 therapeutic supratherapeutic concentration cardiac repolarization , specifically , Fridericia 's QT-Interval ( QTcF )</brief_summary>
	<brief_title>ANX-188 Thorough QT/QTc Study Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy male female subject age 18 65 ( inclusive ) good health determine past medical history , physical examination , vital sign , electrocardiogram , laboratory test screen . Participation clinical trial within last 60 day Pregnant lactate female Use prescription drug , herbal , overthecounter medication within 14 day prior study day 2 Uncontrolled cardiac arrhythmia , cardiac valve abnormality , normal sinus rhythm Smokers tobacco product user prior 3 month Presence clinically significant illness Other protocol define inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>